This #commentary from Cedric HERMANS MD PhD FRCP discusses the use of activated prothrombinase complex concentrate in patients on #emicizumab.
www.rpthjournal.org/article/S247...
The original article being discussed is here:
www.rpthjournal.org/article/S247...
Emicizumab (EMI), a bispecific monoclonal antibody that mimics the function of activated factor (F)VIII and is not recognized by anti-FVIII antibodies, has established itself as the prophylactic…
